The Influence of Heart Failure Self-care on Health Outcomes: Hypothetical Cardioprotective Mechanisms

Lapses in self-care are commonly cited as a major cause of poor outcomes in persons with heart failure (HF). Not surprisingly, self-care is assumed to be central to improving health outcomes in this patient population. Empirically, however, this assumption is not well supported, and mechanistically, relationships between self-care and outcomes in HF have not yet been described. In this review, it is proposed that effective self-care maintenance (adherence) and self-care management (symptom evaluation and management) practices are complementary to optimal medical management in delaying HF progression and improving health outcomes in this population. Potential mechanisms through which effective HF self-care practices are complementary to pharmacological therapy in improving outcomes include (a) facilitating partial blockade and partial deactivation of deleterious neurohormones, (b) limiting inflammatory processes, (c) decreasing the need for administration of detrimental pharmacological agents, and (d) minimizing myocardial hibernation. Because these mechanisms are hypothetical, research findings are required to establish their validity. Several strategic research questions are proposed.

[1]  David C. Sheridan,et al.  Resting Myocardial Blood Flow Is Impaired in Hibernating Myocardium: A Magnetic Resonance Study of Quantitative Perfusion Assessment , 2005, Circulation.

[2]  R. Califf,et al.  Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST). , 1999, American heart journal.

[3]  A. Katz Heart failure: a hemodynamic disorder complicated by maladaptive proliferative responses , 2003, Journal of cellular and molecular medicine.

[4]  S. Yusuf,et al.  Acute precipitants of congestive heart failure exacerbations. , 2001, Archives of internal medicine.

[5]  G. Schuler,et al.  Effect of exercise on coronary endothelial function in patients with coronary artery disease. , 2000, The New England journal of medicine.

[6]  B. Riegel,et al.  Development and testing of a clinical tool measuring self-management of heart failure. , 2000, Heart & lung : the journal of critical care.

[7]  R. Schrier,et al.  Pathophysiology of volume overload in acute heart failure syndromes. , 2006, The American journal of medicine.

[8]  Karl Swedberg,et al.  Nonpharmacologic measures and drug compliance in patients with heart failure: data from the EuroHeart Failure Survey. , 2007, The American journal of cardiology.

[9]  I. Borini,et al.  State of the art of cardiac surgery in patients with congenital heart disease , 2007, Journal of cardiovascular medicine.

[10]  D. Giurgiutiu,et al.  Utilization efficacy of noninvasive and invasive cardiac testing among stable cardiac patients undergoing noncardiac surgery. , 2006, Cardiovascular revascularization medicine : including molecular interventions.

[11]  B. Riegel,et al.  Predictors of self-care in persons with heart failure. , 1999, Heart & lung : the journal of critical care.

[12]  V. Hasselblad,et al.  Relation between dose of loop diuretics and outcomes in a heart failure population: Results of the ESCAPE Trial , 2007, European journal of heart failure.

[13]  J. Granton,et al.  Science Review: Vasopressin and the cardiovascular system part 2 – clinical physiology , 2003, Critical care.

[14]  D. DeMets,et al.  Effect of carvedilol on survival in severe chronic heart failure. , 2001, The New England journal of medicine.

[15]  A. Kurtz,et al.  Blood Pressure–Dependent Inhibition of Renin Secretion Requires A1 Adenosine Receptors , 2005, Hypertension.

[16]  D. Webb,et al.  Endothelin as a regulator of cardiovascular function in health and disease , 1998, Journal of hypertension.

[17]  K. Dracup,et al.  Treatment-seeking delays in heart failure patients. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  A. Michalsen,et al.  Preventable causative factors leading to hospital admission with decompensated heart failure , 1998, Heart.

[19]  D. Newby,et al.  Neutral Endopeptidase Inhibition Augments Vascular Actions of Bradykinin in Patients Treated With Angiotensin-Converting Enzyme Inhibition , 2004, Hypertension.

[20]  G. Huster,et al.  Characterization of the precipitants of hospitalization for heart failure decompensation. , 1998, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[21]  D. Gaze The role of existing and novel cardiac biomarkers for cardioprotection. , 2007, Current opinion in investigational drugs.

[22]  P. Macfarlane,et al.  Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial , 2003, The Lancet.

[23]  S. O'Rourke Antianginal actions of beta-adrenoceptor antagonists. , 2007, American journal of pharmaceutical education.

[24]  Douglas L Mann,et al.  Inflammatory mediators and the failing heart: past, present, and the foreseeable future. , 2002, Circulation research.

[25]  Allison R Webel,et al.  Daily Variability in Dyspnea, Edema and Body Weight in Heart Failure Patients , 2007, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[26]  M. Packer The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. , 1992, Journal of the American College of Cardiology.

[27]  Mario Petretta,et al.  Effects of different degrees of sympathetic antagonism on cytokine network in patients with ischemic dilated cardiomyopathy. , 2005, Journal of cardiac failure.

[28]  B. Bozkurt,et al.  Basic mechanisms in heart failure: the cytokine hypothesis. , 1996, Journal of cardiac failure.

[29]  C. Hengstenberg,et al.  Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels. , 2005, International journal of cardiology.

[30]  S. Anker,et al.  Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure , 2000, Circulation.

[31]  P. Tricoci,et al.  Poor oral health is associated with coronary heart disease and elevated systemic inflammatory and haemostatic factors. , 2004, Journal of clinical periodontology.

[32]  Corrine Y Jurgens,et al.  Somatic awareness, uncertainty, and delay in care-seeking in acute heart failure. , 2006, Research in nursing & health.

[33]  M. Sebern,et al.  Psychometric testing of the self-care of heart failure index. , 2004, Journal of cardiac failure.

[34]  T. Kanda,et al.  Interleukin-6 and cardiovascular diseases. , 2004, Japanese heart journal.

[35]  G. Fonarow Acute decompensated heart failure: challenges and opportunities. , 2007, Reviews in cardiovascular medicine.

[36]  S. Anker,et al.  Tumour necrosis factor-alpha and the failing heart--pathophysiology and therapeutic implications. , 2004, Basic research in cardiology.

[37]  W. Abraham,et al.  Hormones and hemodynamics in heart failure. , 1999, The New England journal of medicine.

[38]  B. Riegel,et al.  A Situation-Specific Theory of Heart Failure Self-care , 2008, The Journal of cardiovascular nursing.

[39]  D. Webb,et al.  Endothelin antagonism in pulmonary hypertension, heart failure, and beyond , 2005, Heart.

[40]  P. Aukrust,et al.  Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approaches. , 2005, The American journal of cardiology.

[41]  David D. Shin,et al.  Congestion is an important diagnostic and therapeutic target in heart failure. , 2006, Reviews in cardiovascular medicine.

[42]  H. Abu‐Saad,et al.  Self-care behaviour of patients with heart failure. , 2000, Scandinavian journal of caring sciences.

[43]  G. Schuler,et al.  Invasive assessment of bacterial endotoxin and inflammatory cytokines in patients with acute heart failure , 2003, European journal of heart failure.

[44]  G. Garin,et al.  Vascular shear stress and activation of inflammatory genes , 2006, Current atherosclerosis reports.

[45]  G. Fonarow,et al.  Relation of loop diuretic dose to mortality in advanced heart failure. , 2006, The American journal of cardiology.

[46]  N. Tkacs,et al.  Current Concepts of Neurohormonal Activation in Heart Failure: Mediators and Mechanisms , 2008, AACN advanced critical care.

[47]  John Mullooly,et al.  Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. , 2003, The New England journal of medicine.

[48]  C. Ferrario,et al.  Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. , 2006, The American journal of cardiology.

[49]  P. Poole‐Wilson,et al.  Should beta‐blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET , 2007, European journal of heart failure.

[50]  T. Ueland,et al.  Inflammatory and anti‐inflammatory cytokines in chronic heart failure: Potential therapeutic implications , 2005, Annals of medicine.

[51]  N. Khaper,et al.  Inflammatory cytokines and postmyocardial infarction remodeling. , 2004, Circulation research.

[52]  M. Domanski,et al.  Diuretic use, progressive heart failure, and death in patients in the DIG study. , 2006, Journal of cardiac failure.

[53]  Salim Yusuf,et al.  Effects of exercise training in patients with heart failure: the Exercise Rehabilitation Trial (EXERT). , 2002, American heart journal.

[54]  J. Ulrich [Physiology of the heart]. , 1950, Zeitschrift fur Kreislaufforschung.

[55]  S. Yusuf,et al.  Risk of hospitalization during influenza season among a cohort of patients with congestive heart failure , 2006, Epidemiology and Infection.

[56]  M. Gheorghiade,et al.  Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes. , 2005, The American journal of cardiology.

[57]  W. Mosterd,et al.  Safety and effects of physical training in chronic heart failure. Results of the Chronic Heart Failure and Graded Exercise study (CHANGE) , 1999, European heart journal.

[58]  H. Ruskoaho Cardiac hormones as diagnostic tools in heart failure. , 2003, Endocrine reviews.

[59]  T. Lennie Nutrition Self-care in Heart Failure: State of the Science , 2008, The Journal of cardiovascular nursing.

[60]  D. Dávila,et al.  Mechanisms of neurohormonal activation in chronic congestive heart failure: pathophysiology and therapeutic implications. , 2005, International journal of cardiology.

[61]  P. Hauptman Medication adherence in heart failure , 2008, Heart Failure Reviews.

[62]  K. Dickstein,et al.  [Executive summary of the guidelines on the diagnosis and treatment of acute heart failure]. , 2005, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[63]  J. Heywood,et al.  Optimal use of diuretics in patients with heart failure , 2007, Current treatment options in cardiovascular medicine.

[64]  P. Persson Renin: origin, secretion and synthesis , 2003, Journal of Physiology.

[65]  J. Nessler,et al.  Concentration of BNP, endothelin 1, pro-inflammatory cytokines (TNF-alpha, IL-6) and exercise capacity in patients with heart failure treated with carvedilol. , 2008, Kardiologia polska.

[66]  S. Anker,et al.  Tumour necrosis factor-α and the failing heart , 2003, Basic Research in Cardiology.

[67]  A. Ferreira,et al.  The effect of dietary sodium restriction on neurohumoral activity and renal dopaminergic response in patients with heart failure , 2004, European journal of heart failure.

[68]  M. Gheorghiade,et al.  Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. , 2006, European heart journal.

[69]  G. Lip,et al.  Hibernating myocardium in heart failure , 2005, Expert review of cardiovascular therapy.

[70]  Irina Cleemput,et al.  Economic implications of non-compliance in health care , 2002, The Lancet.

[71]  J. N. Sharma The kallikrein-kinin system: from mediator of inflammation to modulator of cardioprotection , 2006, InflammoPharmacology.

[72]  A. Farré,et al.  Heart Failure, Redox Alterations, and Endothelial Dysfunction , 2001, Hypertension.

[73]  Christopher M O'Connor,et al.  Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study. , 2003, Journal of the American College of Cardiology.

[74]  P. F. F. G. R. Heyndrickx M.D. Hibernating myocardium , 2004, Basic Research in Cardiology.

[75]  B. Riegel,et al.  Psychometric Testing of the Heart Failure Somatic Awareness Scale , 2006, The Journal of cardiovascular nursing.

[76]  S. Vatner,et al.  Hibernating myocardium. , 1998, The New England journal of medicine.